ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $153,961 (100.0% shares, 0.0% debt)

Holdings (7)

— EQRX, INC. 52.4%

Value ($000) $80,665 Shares 36,335,375 Est. Cost $6.82 Unrealized —

— VERVE THERAPEUTICS, INC. 17.3%

Value ($000) $26,637 Shares 2,008,809 Est. Cost $36.87 Unrealized —

ERAS ERASCA, INC. 14.1%

Value ($000) $21,779 Shares 11,055,554 Est. Cost $17.12 Unrealized -85.0%

DNLI DENALI THERAPEUTICS, INC. 9.3%

Value ($000) $14,312 Shares 693,749 Est. Cost $26.20 Unrealized -3.2%

GOSS GOSSAMER BIO, INC. 4.4%

Value ($000) $6,709 Shares 8,055,916 Est. Cost $1.15 Unrealized 0.0%

— UNITY BIOTECHNOLOGY, INC. 1.6%

Value ($000) $2,412 Shares 1,004,817 Est. Cost $0.40 Unrealized —

— SINGULAR GENOMICS SYSTEMS, INC. 0.9%

Value ($000) $1,447 Shares 3,798,926 Est. Cost $11.56 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	EQRX, INC.	36,335,375	$80,665	52.4%	$6.82	—	COM	26886C107
—	VERVE THERAPEUTICS, INC.	2,008,809	$26,637	17.3%	$36.87	—	COM	92539P101
ERAS	ERASCA, INC.	11,055,554	$21,779	14.1%	$17.12	-85.0%	COM	29479A108
DNLI	DENALI THERAPEUTICS, INC.	693,749	$14,312	9.3%	$26.20	-3.2%	COM	24823R105
GOSS	GOSSAMER BIO, INC.	8,055,916	$6,709	4.4%	$1.15	0.0%	COM	38341P102
—	UNITY BIOTECHNOLOGY, INC.	1,004,817	$2,412	1.6%	$0.40	—	COM	91381U200
—	SINGULAR GENOMICS SYSTEMS, INC.	3,798,926	$1,447	0.9%	$11.56	—	COM	82933R100